18554979. CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES simplified abstract (The Regents of the University of California)
Contents
CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES
Organization Name
The Regents of the University of California
Inventor(s)
Nicole Steinmetz of La Jolla CA (US)
Jooneon Park of La Jolla CA (US)
Young Hun Chung of La Jolla CA (US)
CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES - A simplified explanation of the abstract
This abstract first appeared for US patent application 18554979 titled 'CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES
Simplified Explanation: This patent application discusses methods and compositions for treating cancer using nanoparticles and peptides that target S100A9.
Key Features and Innovation:
- Combination of nanoparticles and peptides for cancer treatment
- Targeting S100A9 protein for specific cancer therapy
Potential Applications: The technology can be used in various cancer treatments, especially those involving S100A9 protein.
Problems Solved: This technology addresses the need for more targeted and effective cancer treatments.
Benefits:
- Improved cancer treatment outcomes
- Targeted therapy with reduced side effects
Commercial Applications: Potential commercial applications include pharmaceuticals for cancer treatment and research tools for studying S100A9-related cancers.
Prior Art: Readers can start searching for prior art related to nanoparticles in cancer treatment and peptides targeting specific proteins in cancer therapy.
Frequently Updated Research: Stay updated on the latest research on nanoparticles, peptides, and cancer treatment for advancements in this field.
Questions about Cancer Treatment with Nanoparticles and Peptides: 1. How do nanoparticles enhance cancer treatment compared to traditional methods? 2. What are the challenges in developing peptides that target specific proteins in cancer therapy?
Original Abstract Submitted
Methods and compositions for the treatment of cancer provided herein. The compositions and methods contain a nanoparticle and a peptide that targets S100A9.
